296 related articles for article (PubMed ID: 24451437)
1. Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review.
McShane CM; Murray LJ; Landgren O; O'Rorke MA; Korde N; Kunzmann AT; Ismail MR; Anderson LA
Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):332-42. PubMed ID: 24451437
[TBL] [Abstract][Full Text] [Related]
2. Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study.
Lindqvist EK; Goldin LR; Landgren O; Blimark C; Mellqvist UH; Turesson I; Wahlin A; Björkholm M; Kristinsson SY
Blood; 2011 Dec; 118(24):6284-91. PubMed ID: 21998210
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for monoclonal gammopathy of undetermined significance: a systematic review.
Castaneda-Avila MA; Ulbricht CM; Epstein MM
Ann Hematol; 2021 Apr; 100(4):855-863. PubMed ID: 33416902
[TBL] [Abstract][Full Text] [Related]
4. History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study.
Lindqvist EK; Landgren O; Lund SH; Turesson I; Hultcrantz M; Goldin L; Björkholm M; Kristinsson SY
Ann Hematol; 2017 Feb; 96(2):261-269. PubMed ID: 27807648
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance.
Baldursdóttir TR; Löve ÞJ; Gíslason GK; Björkholm M; Mellqvist UH; Lund SH; Blimark CH; Turesson I; Hultcrantz M; Landgren O; Kristinsson SY
Eur J Haematol; 2021 Mar; 106(3):380-388. PubMed ID: 33295006
[TBL] [Abstract][Full Text] [Related]
6. Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance.
Sigurbergsdóttir AÝ; Love TJ; Kristinsson SY
Front Immunol; 2022; 13():876271. PubMed ID: 35572590
[TBL] [Abstract][Full Text] [Related]
7. Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.
Greenberg AJ; Rajkumar SV; Vachon CM
Blood; 2012 Jun; 119(23):5359-66. PubMed ID: 22354002
[TBL] [Abstract][Full Text] [Related]
8. Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias.
Zou D; An G; Zhu G; Wang J; Shi L; Meng H; Xu Y; Sui W; Deng S; Zhan F; Qiu L
Biol Blood Marrow Transplant; 2014 Mar; 20(3):319-25. PubMed ID: 24296491
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal Gammopathy of Undetermined Significance: Current Concepts and Future Prospects.
Seth S; Zanwar S; Vu L; Kapoor P
Curr Hematol Malig Rep; 2020 Apr; 15(2):45-55. PubMed ID: 32222885
[TBL] [Abstract][Full Text] [Related]
10. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
Stelmach-Gołdyś A; Czarkowska-Paczek B
Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
[TBL] [Abstract][Full Text] [Related]
11. Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study.
Chang SH; Luo S; O'Brian KK; Thomas TS; Colditz GA; Carlsson NP; Carson KR
Lancet Haematol; 2015 Jan; 2(1):e30-6. PubMed ID: 26034780
[TBL] [Abstract][Full Text] [Related]
12. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
[TBL] [Abstract][Full Text] [Related]
13. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.
Brown LM; Gridley G; Check D; Landgren O
Blood; 2008 Apr; 111(7):3388-94. PubMed ID: 18239085
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
Shimanovsky A; Alvarez Argote J; Murali S; Dasanu CA
BBA Clin; 2016 Dec; 6():12-8. PubMed ID: 27331023
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience.
Alfano G; Fontana F; Colaci E; Messerotti A; Bettelli F; Potenza L; Luppi M; Cappelli G
Transplantation; 2017 Nov; 101(11):e337-e342. PubMed ID: 28731904
[TBL] [Abstract][Full Text] [Related]
17. Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study.
Campbell JP; Heaney JLJ; Pandya S; Afzal Z; Kaiser M; Owen R; Child JA; Cairns DA; Gregory W; Morgan GJ; Jackson GH; Bunce CM; Drayson MT
Lancet Haematol; 2017 Dec; 4(12):e584-e594. PubMed ID: 29146225
[TBL] [Abstract][Full Text] [Related]
18. Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study.
Landgren O; Linet MS; McMaster ML; Gridley G; Hemminki K; Goldin LR
Int J Cancer; 2006 Jun; 118(12):3095-8. PubMed ID: 16395700
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
[TBL] [Abstract][Full Text] [Related]
20. Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study.
Sverrisdóttir IS; Lund SH; Turesson I; Björkholm M; Goldin LR; Landgren O; Kristinsson SY
Br J Haematol; 2019 Jul; 186(1):37-44. PubMed ID: 30906990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
